Skip to content

Research on Perioperative Rehabilitation of Left Ventricular Assist Device Implantation Surgery

Research on Perioperative Rehabilitation of Left Ventricular Assist Device Implantation Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112504
Enrollment
Unknown
Registered
2025-11-14
Start date
2025-11-15
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cardiac failure

Interventions

Intervention group:1. Preoperative Intervention (5 times per week for 2 weeks) (1) Rehabilitation Education: Abdominal breathing and enhanced limb mobility (2) Cycling Training: Target heart
3 exercises × 10 repetitions × 3 sets, 5–10 min, RPE 11–13 (4) Respiratory Function Training: 30% MIP, 30% MEP
if patient RPE < 5, increase load by 5% in the next session
5–10 min per session, RPE 11–13 2. Postoperative Intervention (Start 1 week after surgery, 5 times per week for 2 weeks) (1) Respiratory Function Training: Same as preoperative intervention
one set morning and evening, 10 repetitions per set 3) Indoor walking: 3 min per session, 2 sessions per day 4) Outdoor walking: 5 min per session, 2 sessions per day 5) Cyclin
Control group:1. Preoperative Intervention (5 times per week for 2 weeks) Rehabilitation education and routine nursing: Abdominal breathing and enhanced limb mobility 2. Postoperative Interven

Sponsors

Beijing Anzhen Hospital, affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 80 years; 2. Patients scheduled for elective implantation of a left ventricular assist device (LVAD); 3. Meet the surgical indications for LVAD implantation as defined in the Chinese Expert Consensus on Preoperative Evaluation and Management of LVAD Candidates (2023); 4. Understand the content of this study, voluntarily participate, and provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Experienced acute myocardial infarction, fulminant myocarditis, or stroke within 1 month prior to enrollment; 2. Presence of severe respiratory disease, including severe pulmonary disease (FEV1% predicted < 50%); 3. Severe hepatic or renal dysfunction (Child-Pugh class C or eGFR < 30 mL/min/1.73 m^2); 4. History of stroke with associated motor dysfunction; 5. Cognitive impairment preventing understanding or participation in rehabilitation training; 6. Any other condition deemed by the investigator to be unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
6-Minute Walk Distance;

Secondary

MeasureTime frame
Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP) at preoperative day 15, preoperative day 1, and postoperative day 21;FEV? % Predicted at preoperative day 15, preoperative day 1, and postoperative day 21;Handgrip Strength at preoperative day 15, preoperative day 1, and postoperative day 21;Duration of mechanical ventilation;Length of stay in the ICU;EQ-5D-5L scale score;GAD-7 scale score;PHQ-9 scale score;PSQI scale score;Postoperative hospital stay;The incidence rate of pulmonary-related adverse events after surgery;

Countries

China

Contacts

Public ContactWu Jiahui

Beijing Anzhen Hospital, affiliated to Capital Medical University

wujiahui1998@163.com+86 186 1050 6708

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026